The Emerging Mycotoxin 2-Amino-14, 16-Dimethyloctadecan-3-ol (AOD) Alters Transcriptional Regulation and Sphingolipid Metabolism and Undergoes <i>N</i>-Acylation by HepG2 Cells.

Toxins (Basel) · 2025 · PMC12390525 · PMID 40864089

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a marginal trendno p-value reported

Western blotting analysis revealed a significant accumulation of cleaved caspase-3 products (19 kDa) in AOD- and m18:0-treated cells, whereas d18:0 treatment exhibited only a marginal trend toward proteolytic activation ( Figure S1B ).

also in 147 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

The Emerging Mycotoxin 2-Amino-14, 16-Dimethyloctadecan-3-ol (AOD) Alters Transcriptional Regulation and Sphingolipid Metabolism and Undergoes &lt;i&gt;N&lt;/i&gt;-Acylation by HepG2 Cells.

The sentences

The Emerging Mycotoxin 2-Amino-14, 16-Dimethyloctadecan-3-ol (AOD) Alters Transcriptional Regulation and Sphingolipid Metabolism and Undergoes <i>N</i>-Acylation by HepG2 Cells.